Sympathetic ophthalmia.
BACKGROUND
Sympathetic ophthalmia (SO) is a rare, bilateral, non-necrotizing, granulomatous uveitis that occurs after ocular trauma or surgical procedures to one eye threatening sight in the fellow eye. The pathophysiology is not clearly understood, but it appears that the disrupted integrity of the inciting eye leads to an autoimmune hypersensitivity reaction against the exposed ocular antigens in the injured eye as well as in the sympathizing eye. More recently, vitreoretinal surgery has been noted to be a risk factor for the development of SO.


METHODS
Medline search for case reports of sympathetic ophthalmia with links to full text in English yielded articles for review of patient demographics, clinical presentation and examination, therapies and final visual acuity.


RESULTS
Eighty-six patients with SO were included in this review. Sixty-two patients were male and 24 were female with an average age of 46 years. Injuries accounted for 47% of patients while ocular surgery was reported in 44% of patients with pars plana vitrectomy occurring in 21%. Most patients reported reduced vision and presented with uveitis. Ninety-five percent of them received systemic corticosteroid therapy and 75% of patients also received immunomodulators. About 70% of patients had improved visual acuity in their sympathizing eye at their last reported evaluation.


CONCLUSIONS
Sympathetic ophthalmia warrants prompt evaluation and treatment to maintain a favorable visual outcome. Ocular surgeries including vitreoretinal surgery and cyclodestructive procedures have been noted to be risk factors for the development of sympathetic ophthalmia. With current medical management including corticosteroids and immunomodulators visual prognosis is relatively good.
Castiblanco
Claudia Patricia
CP
Retina Service, Yale University Eye Center, 330 Cedar Street, Boardman Building 110, New Haven, CT 06510-3218, USA.
Adelman
Ron A
RA
D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009879:Ophthalmia, Sympathetic / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D014786:Vision Disorders / Q000503:physiopathology; D014792:Visual Acuity / Q000502:physiology
D005938:Glucocorticoids; D007155:Immunologic Factors
Ophthalmic Plast Reconstr Surg. 2006 Mar-Apr;22(2):133-4
16550060
Int Ophthalmol Clin. 2002 Summer;42(3):179-85
12131594
Ocul Immunol Inflamm. 1993;1(3):255-62
22822781
Arch Ophthalmol. 2004 Oct;122(10):1568-9
15477482
Arch Ophthalmol. 1998 Feb;116(2):249-50
9488284
Ophthalmology. 1980 Feb;87(2):109-21
7383540
Acta Ophthalmol Scand. 2006 Jun;84(3):436
16704716
Clin Exp Ophthalmol. 2004 Apr;32(2):196-8
15068439
Br J Ophthalmol. 2004 Mar;88(3):438
14977788
Br J Ophthalmol. 2001 Apr;85(4):496
11302127
Ocul Immunol Inflamm. 2003 Mar;11(1):61-5
12854028
Eye (Lond). 1997;11 ( Pt 2):213-6
9349415
Retina. 2004 Aug;24(4):637-45
15300097
Trans Am Ophthalmol Soc. 1975;73:251-63
1246807
Am J Ophthalmol. 2006 Mar;141(3):498-507
16490496
Br J Ophthalmol. 2000 May;84(5):448-9
10781505
Graefes Arch Clin Exp Ophthalmol. 2005 Jul;243(7):734-6
15756580
Curr Opin Ophthalmol. 2000 Oct;11(5):372-86
11148706
Can J Ophthalmol. 2006 Aug;41(4):494-6
16883368
Clin Exp Ophthalmol. 2005 Feb;33(1):5-9
15670071
Retina. 2005 Apr-May;25(3):375-7
15805921
Br J Ophthalmol. 2000 Mar;84(3):259-63
10684834
Ophthalmic Surg Lasers Imaging. 2005 Mar-Apr;36(2):163-6
15792321
Retina. 2006 Feb;26(2):243-7
16467694
Ophthalmic Plast Reconstr Surg. 2003 Nov;19(6):417-20; discussion 420
14625486
Int Ophthalmol Clin. 1990 Fall;30(4):279-85
2228475
Eye (Lond). 2003 Jul;17(5):666-7
12855987
Ophthalmic Plast Reconstr Surg. 1999 Jan;15(1):4-8
9949422
Retina. 2002 Feb;22(1):109-11
11884890
Am J Ophthalmol. 2004 Feb;137(2):367-8
14962439
Ophthalmic Plast Reconstr Surg. 2005 Jul;21(4):316-8
16052152
Eye (Lond). 2006 Nov;20(11):1306-7
16691261
Ophthalmology. 1982 Nov;89(11):1291-2
7155538
Arch Ophthalmol. 1995 May;113(5):597-600
7748129
Ocul Immunol Inflamm. 2005 Feb;13(1):85-6
15804775
Semin Ophthalmol. 2005 Jul-Sep;20(3):191-7
16282154
Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4245-50
16249504
Am J Ophthalmol. 2001 Oct;132(4):585-7
11589890
Surv Ophthalmol. 1979 Nov-Dec;24(3):141-56
396680
Ocul Immunol Inflamm. 2002 Sep;10(3):223-7
12789598
Int Ophthalmol Clin. 1982 Fall;22(3):125-39
7107131
Clin Exp Ophthalmol. 2004 Oct;32(5):542-5
15498072
Surv Ophthalmol. 1989 Jul-Aug;34(1):1-14
2678549
Surv Ophthalmol. 1997 May-Jun;41(6):433-59
9220567
Retina. 2001;21(2):146-54
11321141
Int Ophthalmol. 1982 Feb;4(3):129-35
7068330
Int Ophthalmol Clin. 2000 Winter;40(1):69-84
10713915
Br J Ophthalmol. 2007 Mar;91(3):399-401
17322472
Graefes Arch Clin Exp Ophthalmol. 2006 Oct;244(10):1353-6
16523295
Trans Am Ophthalmol Soc. 1970;68:105-12
4332690
JNMA J Nepal Med Assoc. 2005 Apr-Jun;44(158):57-9
16554873
Am J Ophthalmol. 1953 Aug;36(8):1100-20
13080376
Ophthalmology. 2002 Aug;109(8):1527-31
12153806
Graefes Arch Clin Exp Ophthalmol. 2006 Feb;244(2):253-8
15999259
Graefes Arch Clin Exp Ophthalmol. 1998 Aug;236(8):635-8
9717662
Br J Ophthalmol. 2001 Mar;85(3):281-6
11222331